Here are over 10 can't-miss events for Houston innovators in September. Photo via Getty Images

From energized tech conferences to informative speaker series, September is filled with opportunities for Houston innovators. Here's a roundup of events you won't want to miss out on so mark your calendars and register accordingly.

Go ahead and add the Houston Innovation Awards on November 14 to your agenda as well — and submit a nomination of a deserving Houston startup or innovator online.

Note: This post may be updated to add more events.

September 4-5 — EcoEngineers' Life-Cycle Analysis Academy

A life-cycle analysis (LCA) is a systematic and comprehensive method for evaluating the environmental impact of a product, service, or system from its inception to its end-of-life.

EcoEngineers has performed more than 1,000 carbon LCAs since 2015 and will guide attendees through the leading industry trends and regulations impacting LCAs. The LCA Academy provides an opportunity for industry leaders and practitioners across all sectors to gain hands on experience in a workshop environment.

This event is Wednesday, September 4, and Thursday, September 5, from 8 am to 5 pm at Petroleum Club. Click here to register.

September 5 — Leading Successful Projects: Managing Risk and Uncertainty with New Technology Implementations

Join RCEL at the Ion for an informative discussion on managing risk and uncertainty in new technology projects. Register to attend and enjoy refreshments, along with an opportunity for networking and discussion following a seminar on navigating risks and uncertainties in new technology applications.

During this seminar, Dr. Claudia Zettner, a Rice University professor will provide real-world examples of new technology implementations and how realized risks affected overall project outcomes.

This event is on Thursday, September 5, from 4 to 5:30 pm at the Ion. Click here to register.

September 9-13 — Houston Energy and Climate Startup Week

Greentown Labs, Halliburton Labs, and The Rice Alliance for Technology and Entrepreneurship are joining forces to launch the inaugural Houston Climate and Energy Startup Week 2024. This week will bring together leading energy and climate investors, industry leaders, and startups from across the globe to showcase and discuss innovative and promising companies and technologies that are transforming the energy industry and driving a sustainable, low-carbon energy future.

This event begins Monday, September 9, at 3:30 pm and runs through, Friday, September 13. Click here for the full schedule and to register.

September 9-13 — Houston Energy and Climate Week

Allies in Energy, a 501c3 non-profit, was formed in Texas to address energy education and climate literacy, and will be hosting their inaugural Houston Energy & Climate Week. This week brings together major cities in creating the national conversations and actions around a net zero future and Houston's leading role in driving solutions. The program themes are energy, innovation, industry, food, environmental justice, health, finance, workforce, community engagement, and policy.

This event begins Monday, September 9, at 7 am and runs through September 13. Click here for the full schedule and to register.

September 11 — Houston Methodist Clinician Speaker Series - Dr. Jordan Dale

Houston Methodist's next clinician speaker is Dr. Jordan Dale, the chief medical information officer. Dale will speak about digital transformation at Houston Methodist, the role of artificial intelligence in healthcare, and the importance of responsible AI use.

This event is Wednesday, September 11, from 4:45 to 6 pm at the Ion. Click here to register.

September 12 — Future of Automated Science Symposium

The Future of Automated Science Symposium is the inaugural annual event focused on automated science. As a new and emerging field, bringing together AI, infrastructure at scale, and high-throughput experimentation, Automated Science can offer new paradigms for scientific investigation.

Hear from academic and industry leaders from Carnegie Mellon University, Emerald Cloud Lab, and Opentrons. Learn about the exciting future of Automated Science and network with like-minded scientists and engineers.

This event is on Thursday, September 12, from 8:30 am to 4:15 pm at TMC Helix Park. Click here to register.

September 13 — 17th Annual Advances in Neurology Symposium

There have been significant advances in the diagnosis and treatment of many neurological diseases. Attempts to cover these scientific advances have been made through peer-reviewed journals, national and international society meetings, and consensus statements. This program will emphasize evidence-based strategy for the current treatment of neurological disorders and cutting-edge research in novel therapeutics.

This event is on Friday, September 13, from 8 am to 5:15 pm at Houston Methodist Research Institute. Click here to register.

September 17-20 — Gastech Conference

The Gastech Conference is an essential forum for energy professionals to shape the future of the industry. It sets the industry's critical agenda by driving energy security and transitions. More than 1,000 speakers will discuss the real-world strategies and business models that deliver energy security, shape climate actions for industry-wide decarbonization, and support a sustainable, affordable, and reliable multi-faceted energy system.

This event begins Tuesday, September 17 at 10 am and runs through Friday September 20 at George R. Brown Convention Center. Click here for the full schedule and to register.

September 19 — Carbon to Value Initiative Year 4 Kickoff

The Carbon to Value (C2V) Initiative is a multi-year collaboration between The Urban Future Lab (UFL), Greentown Labs, and Fraunhofer USA. This partnership is driving the creation of a thriving innovation ecosystem for the commercialization of carbontech—technologies that capture, convert and store carbon dioxide (CO₂) into valuable end products or services.

Celebrate the kickoff of Year 4 of the Carbon to Value Initiative, meet the startups that were selected for this year’s cohort, and hear from industry experts.

This event is on Thursday, September 19, from 5:30 pm to 8 pm at Greentown Labs. Click here to register.

September 24 — TMC Cappucino Connections

Mingle with the Texas Medical Center community and learn about exciting upcoming projects while enjoying complimentary cups of coffee.

This event is on Tuesday, September 24 from 8:30 to 10:30 am at TMC Innovation Factory. Click here to register.

September 25-27 — Innovation for Day One

Innovation for Day One is a conference organized by the Rice360 Institute for Global Health Technologies and the maternal newborn health community to explore groundbreaking tools and approaches for healthy outcomes for mothers and babies in resource-limited communities.

This event is from Wednesday, September 25 through Friday, September 27, at the Bioscience Research Collaborative on Rice University's campus. Click here to register.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.